← Eichor
Condition: Liquid Biopsy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Liquid Biopsy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NA · 8 location(s) · Tianjin Medical University Second Hospital · NCT07180212FOLICOLOR TRIAL: Following Therapy Response Through Liquid Biopsy in Metatstatic Colorectal Cancer Patients
Phase 3 · 9 location(s) · University Hospital, Antwerp · NCT07558083Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2 · 3 location(s) · Tianjin Medical University Second Hospital · NCT07475403ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
Phase N/A · 1 location(s) · Gene Solutions · NCT06589388Feasibility Study Aiming at Pre-Analytical Standardization of Whole Blood Processing for Liquid Biopsy Applications
Phase N/A · 1 location(s) · Tethis S.p.A. · NCT05942066Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT07399977Collection of Lung Fluid and Tissue Samples for Research
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00471250Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
Phase 3 · 1 location(s) · National Cancer Institute, Naples · NCT06509126Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
Phase N/A · 13 location(s) · Swiss Cancer Institute · NCT07617610LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer
Phase N/A · 8 location(s) · Centre Leon Berard · NCT02511288Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognosticat
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06678724The Jinling Cohort
Phase N/A · 2 location(s) · Nanjing Shihejiyin Technology, Inc. · NCT06011694The circTeloDIAG: Liquid Biopsy for Glioma Tumor
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT04931732Colon Cancer Liquid Biopsy Investigation of Methylation-based Biomarkers Evaluation Using Delta-HLD (CLIMBED)
Phase N/A · 1 location(s) · Epiliquid Holding, Inc · NCT07168876OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NA · 1 location(s) · Gynaecologisch Oncologisch Centrum Zuid · NCT06611072Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT05196087Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
Phase N/A · 1 location(s) · JaxBio Ltd · NCT06963307Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation
Phase N/A · 1 location(s) · LifeOS Genomics Corporation · NCT06573073Liver Cancer and Immunotherapy in the Liquid Biopsy Era
NA · 1 location(s) · University Hospital, Montpellier · NCT05810402Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening
Phase N/A · 4 location(s) · Syantra Inc. · NCT07219277Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Phase 2 · 10 location(s) · Canadian Cancer Trials Group · NCT05601440Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
Phase N/A · 3 location(s) · Gene Solutions · NCT06087120Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD
Phase N/A · 1 location(s) · Epiliquid Holding, Inc · NCT07148297The Added Value of Tissue or Liquid Biopsy NGS Profiling in Advanced Solid Tumor Treatment Decisions.
Phase N/A · 14 location(s) · The Belgian Society of Medical Oncology · NCT07713550CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease
NA · 1 location(s) · British Columbia Cancer Agency · NCT05257967Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Phase N/A · 5 location(s) · San Raffaele University · NCT06708429A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
Phase N/A · 4 location(s) · University of Southern California · NCT06336928Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer
NA · 5 location(s) · Zealand University Hospital · NCT05889247Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03702309In Vivo Liquid Biopsy of Melanoma (Cytophone)
NA · 1 location(s) · Cytoastra · NCT06488365
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.